Some firms will 'grow through the crisis'
J.P. Morgan Cazenove turns 'neutral' on investment trust
Outlooks for the biotech sector
Could spell bottom for value, say experts
Follows 'an extended period of underperformance'
'Unique record' to be maintained
'Reliable source of income'
Increases holding to 50.2% of investment trust
98% of intended trading completed by new manager
Banks 'part of the solution'
Replacing GVQ Investment Management
Discounts as wide as during financial crisis
'Will emerge in a strong position'
In a letter to shareholders
Next generation of dividend heroes
Reducing holding in Perpetual
'The right thing to do'
Latest AIC 'dividend heroes' list
Income funds and debt issues causing problems
Energy stocks and smaller companies hit hardest
'Strategic review' needed
Andrew Lebus to retire in 2021
Breach of obligations